Patent · US Expired

Generation of replication competent viruses for therapeutic use

US7550296B2 · kind B2 · utility

49Cited by

3References

58Claims

0Family size

Assignee

Bayer Schering Pharma AG · DE

Inventors

Terry Hermiston · Corte Madera, US
Fang Jin · Newton, US
Peter Kretschmer · Bruchköbel, DE

Key dates

Filing date	Nov 28, 2005
Grant date	Jun 23, 2009
Priority date	—
Expiry date	Nov 28, 2025

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2830/42
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the generation of replication-competent viruses having therapeutic utility. The replication-competent viruses of the invention can express proteins useful in the treatment of disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.